Test
Increase process yields for the manufacture of monoclonal antibodies (MAbs) with HyClone™ ADCF-MAb Media, a protein-free media containing no animal-derived components.
Content And Storage | 2° to 8°C, away from light |
---|---|
Sterilization Method | 0.2 μm Sterile-filtered |
Description | with L-Glutamine |
With Additives | Glutamine,Poloxamer 188,HEPES,Sodium Bicarbonate |
Product Type | ADCF-mAb Liquid Medium |
Form | Liquid |
Without Additives | No Protein,No Phenol Red |
Shelf Life | 24 Months |
Certifications/Compliance | cGMP |
Content And Storage | 2° to 8°C, away from light |
---|---|
Sterilization Method | 0.2 μm Sterile-filtered |
Product Type | CDM4MAb Liquid Medium |
Form | Liquid |
Shelf Life | 12 Months |
ADCF medium for use with hybridoma and myeloma cell lines.
Increase process yields for manufacturing of human and humanized recombinant antibodies.
Regulatory-friendly medium designed to increase process yields with a variety of NS0 cell clones.
Hybridoma fusion medium (serum-free)
Media and reagents for all steps of monoclonal antibody generation
Myeloma and hybridoma culture medium (serum-containing)
Semi-solid methylcellulose-based hybridoma selection and cloning medium without HAT (serum-containing)
Semi-solid methylcellulose-based hybridoma selection and cloning medium with HAT (serum-containing)
Hybridoma growth medium with hypoxanthine and thymidine (serum-containing)
Hybridoma fusion recovery medium (serum-containing)
Content And Storage | 2 to 8°C |
---|---|
Product Type | Hyclone CDM4MAb Media |
Form | Liquid |
Without Additives | No Glutamine |
Quantity | 500 mL |
Certifications/Compliance | cGMP |
For Use With (Application) | Production of monoclonal antAntibodies (MAbs) from hybridoma and recombinant myeloma cell lines for research, therapeutic and diagnostic purposes is rapidly growing. |